Sanacora, Gerard
Yan, Zhen http://orcid.org/0000-0002-3519-9596
Popoli, Maurizio http://orcid.org/0000-0003-4670-8664
Article History
Accepted: 27 October 2021
First Online: 10 December 2021
Competing interests
: G.S. has served as a consultant for Allergan, Alkermes, AstraZeneca, Avanier Pharmaceuticals, Axsome Therapeutics Biohaven Pharmaceuticals, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb, Clexio, Denovo Biopharma, Engrail Therapeutics, EMA Wellness, Epiodyne, Intra-Cellular Therapies, Janssen, Lundbeck, Merck & Co., Navitor Pharmaceuticals, Neurocrine, Novartis, Noven Pharmaceuticals, Otsuka, Perception Neuroscience, Praxis Therapeutics, Sage Pharmaceuticals, Taisho Pharmaceuticals, Valeant, Vistagen Therapeutics, and XW Labs over the past 36 months; has received research contracts from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Hoffman La-Roche, Merck, Naurex, Servier and Usona over the past 36 months; holds equity in BioHaven Pharmaceuticals; and is a co-inventor on US Patent 8,778,979 held by Yale University and a co-inventor on US Provisional Patent Application No. 047162-7177P1 (00754) filed on 20 August, 2018 by Yale University Office of Cooperative Research. Z.Y. has no competing interests. M.P. has received research contracts from Rodin Therapeutics (now Alkermes) in the last 36 months; and has received research contracts from Merck, GlaxoSmithKline, Servier, Sigma-Tau, Fidia and Abbott.